Dr. Skratt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4001 J St
Sacramento, CA 95819Phone+1 330-493-4443Fax+1 530-622-7853
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Emergency Medicine, 1993 - 1996
Albany Medical CollegeClass of 1993
Certifications & Licensure
CA State Medical License 1995 - 2026- American Board of Emergency Medicine Emergency Medicine
Publications & Presentations
PubMed
- 89 citationsProtection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO BKevin T. Finnegan, John J. Skratt, Ian Irwin, Louis E. DeLanney, J. William Langston
European Journal of Pharmacology. 1990-08-02 - 28 citationsThe N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats.Kevin T. Finnegan, John J. Skratt, Ian Irwin, J W Langston
Neuroscience Letters. 1989-11-06 - 5 citationsα-Fluoromethylhistidine-induced inhibition of brain histidine decarboxylase: Implications for the CO2-trapping enzymatic methodJohn J. Skratt, Lindsay B. Hough, Julia W. Nalwalk, Kim E. Barke
Biochemical Pharmacology. 1994-01-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
